Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_8381805eba6d034fc77bd230dd02e6e2 http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_c36c1580438ff41af470621b5e26877a http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_07c9542186133097bd6bbb7d92393090 http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_5807a1aa4e3cc12e7c08ba242625500c |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N9-22 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-55 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N9-22 |
filingDate |
2020-06-26-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_fe12b6a96a568242b00af0446dab56c3 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_90e561eac43d5a76ecdb6af0f5c04dff |
publicationDate |
2020-12-30-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
WO-2020264361-A1 |
titleOfInvention |
Circular strained zymogen compositions and methods of use |
abstract |
Disclosed herein are circular zymogens of RNase 1 that have a proteolytic cleavage site and are activated by a specific protease. These circular zymogens are useful for treatment of disorders that are characterized by a specific protease (e.g., HIV-1 protease). |
priorityDate |
2019-06-28-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |